Novus Healthcare will exclusively distribute STIMULAN® and genex in South Africa Keele, UK, 10 May 2023 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces that its STIMULAN® products are now available in South Africa for treating bacterial […]
Winner of two Queen’s Awards for Enterprise in Innovation and International Trade Highest year-on-year sales growth in the company’s 25-year history Keele, UK, 14 December 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is celebrating its 25th anniversary […]
STIMULAN® gives surgeons the freedom to choose and combine the antibiotics that support their infection treatment strategy Keele, UK, 29 November 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to announce that STIMULAN® has received a new […]
Consensus group of clinicians have developed a framework of best practice and toolkit for podiatrists treating diabetic foot infections STIMULAN placed in foot wounds following debridement can release antibiotics at therapeutic concentrations Keele, UK, 3 November 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in […]
Keele, UK, 15 June 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to announce two new appointments. Simon Greenhalgh has been appointed Group Chief Financial Officer (CFO) and Pete Webster takes up the position of UK […]
